Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Alan K. Davis, Frederick S. Barrett, Darrick G. May, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 5, pp. 481-481
Open Access | Times Cited: 936
Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons
Corina Nagy, Malosree Maitra, Arnaud Tanti, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 6, pp. 771-781
Open Access | Times Cited: 387
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 287
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
Biochemical Pharmacology (2020) Vol. 177, pp. 113935-113935
Open Access | Times Cited: 188
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah, Henk M. De Feyter, Lynnette A. Averill, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2154-2160
Open Access | Times Cited: 186
The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities
Randal A. Serafini, Kerri D. Pryce, Venetia Zachariou
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 64-73
Open Access | Times Cited: 182
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang, Jianjun Yang, Ailin Luo, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 164
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 164
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah, Lynnette A. Averill, Ralitza Gueorguieva, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 990-997
Open Access | Times Cited: 151
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
Lijia Chang, Kai Zhang, Yaoyu Pu, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 181, pp. 53-59
Closed Access | Times Cited: 148
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 18
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Kyle A. Brown, Todd D. Gould
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1114-1127
Open Access | Times Cited: 17
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 8
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 2
The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder
Chadi G. Abdallah, Lynnette A. Averill, Teddy J. Akiki, et al.
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 171-189
Open Access | Times Cited: 150
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 145
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
Nolan Williams, Boris D. Heifets, Brandon S. Bentzley, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1779-1786
Closed Access | Times Cited: 133
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Panos Zanos, Jaclyn N. Highland, Brent W. Stewart, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 13, pp. 6441-6450
Open Access | Times Cited: 128
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR
W Nowak, Leandro Nicolás Grendas, Liliana M. Sanmarco, et al.
EBioMedicine (2019) Vol. 50, pp. 290-305
Open Access | Times Cited: 116
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 93
Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine
Yihui Cui, Shaohua Hu, Hailan Hu
Trends in Neurosciences (2019) Vol. 42, Iss. 3, pp. 179-191
Closed Access | Times Cited: 80
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
Chadi G. Abdallah, John D. Roache, Ralitza Gueorguieva, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 8, pp. 1574-1581
Open Access | Times Cited: 64
Perspectives for therapy of treatment‐resistant depression
Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Świȩcicki, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4181-4200
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top